Latest: Q2 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$1.8M in Q2 2026 · −$6.1M over twelve months
Operating cash flow−$1.8M
Free cash flow−$1.8M
Cash conversion cycle434 days
Analysis
In Q2 2026, Nexalin Technology generated −$1.8M of operating cash flow. That is $884K less than in Q2 2025 (−$917K).
Over the twelve months to Jun 30, 2026, operating cash flow was −$6.1M; the largest uses were operating cash flow ($6.1M); besides operations, cash came from other investing ($5.3M), other financing ($1.4M); the cash balance rose by $574K.
Operating cash flow was −$1.8M against net income of −$2.2M. The largest differences: stock-based pay +$408K, accrued liabilities +$218K, prepaid and other assets −$212K.
Its cash conversion cycle was 434 days (receivables 359 + inventory 5757 − payables 5681).
Free cash flow
Operating cash flow less capital spending.Latest (Q2 2026): Operating cash flow −$1.8M, Capital spending $0.
Capital allocation, year by year
Over these 5 years operating cash flow totalled −$16.0M; the largest uses were operating cash flow ($16.0M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$2.5M
Debtnone
Net cash$2.5M
Cash runway5 months
Nexalin Technology is burning cash: its operations consume cash, a free cash flow of −$6.1M a year at the current rate against $2.5M of cash and investments: a runway of about 5 months before any new financing.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q2 2026
359
5757
5681
434
Q1 2026
375
7701
10220
-2144
Q4 2025
24
638
683
-21
Q3 2025
172
3882
3590
465
Q2 2025
48
694
841
-99
Q1 2025
30
1161
1120
72
Q4 2024
48
2043
1979
112
Q3 2024
34
1100
919
215
Every quarter
Quarter
Operating cash flow
Cash drawn (+) / kept (−)
Free cash flow
Q2 2026
−$1.8M
$203K
−$1.8M
Q1 2026
−$1.7M
−$553K
−$1.7M
Q4 2025
−$1.1M
−$65K
−$1.1M
Q3 2025
−$1.5M
−$159K
−$1.5M
Q2 2025
−$917K
$191K
−$917K
Q1 2025
−$1.4M
−$48K
−$1.4M
Q4 2024
−$1.1M
−$493K
−$1.1M
Q3 2024
−$800K
$767K
−$800K
Nexalin Technology: income statement and cash flow
Nexalin Technology, Q2 2026: revenue $12K (-83% year over year). The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.